We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Image of Kate Robinson

Kate Robinson

Assistant Editor


Kate graduated from Sheffield Hallam University with a bachelor's degree in biomedical sciences in 2020. During her studies she developed a passion for science communication and after graduating, began a science blog in order to continue writing about trending science news and topics of interest. She joined the editorial team at Technology Networks in 2021. In her role as assistant editor Kate supports the publication’s in-house writers, produces scientific content across all communities and works closely with the managing editor to help coordinate commissioned pieces.


Got a question for Kate Robinson?


Get in touch using the contact form linked here and we’ll get back to you shortly



Published Content
Total: 74
Illustration of two female researchers working at a lab bench.
Article

Women in Science: Motivation, Challenges and Advice

Here, leading female scientists from a range of disciplines discuss why they were drawn to science and what they find most enjoyable about their work, as well as share tips for women looking to embark on a career in science.
A pipette is held above a small tube, held in a scientist's gloved hand.
Industry Insight

Using Gravity To Separate T Cells Could Speed Up Cancer Treatment

While traditional methods of cell sorting come with several challenges, microbubbles are simple to use and can separate cells without causing harm. Technology Networks spoke to Dr. Brandon McNaughton, CEO and co-founder of Akadeum to find out more about this technology, its applications and how it could improve cancer treatment.
An enamel heart-shaped pride badge pinned on a doctor's coat
Article

Look Under the Scope – LGBT+ History Month

The theme for LGBT+ History Month this year is Medicine – #UnderTheScope, celebrating the contribution of LGBT+ individuals to medicine and healthcare. Here, we explore key figures often passed over when recounting significant contributions to medicine.
A doctor holds an empty saliva sample tube.
Industry Insight

Time Is of the Essence: Saliva-Based Test Could Detect Cancer Early

Technology Networks spoke to Nick Ainslie, co-founder of Ausel, to find out more about a saliva-based diagnostic designed to indicate the presence of cancer cells at the earliest stage of development without the need for invasive methods.
Cancer seen in the lungs of a human torso
Industry Insight

Addressing One of the Most Common Dilemmas Faced by Oncologists

Technology Networks spoke to Dr. Ofer Sharon, CEO of OncoHost, to learn about the challenges in non-small cell lung cancer treatment and how proteomics-based analysis could enable personalized cancer treatments.
Small molecule closeup
Industry Insight

Confident Metabolite Identification for Meaningful Results in Multiomics Analyses

In this interview, Technology Networks spoke to Heiko Neuweger, director of Bioinformatics Life Science Mass Spectrometry Software R&D at Bruker, to learn about the importance of target compound annotation and identification, the advantages of integrating collision cross section (CCS) information into workflows and the benefits of CCS-Predict Pro.
Floating cancer cells.
Article

Four New AML Studies Funded by Leukaemia UK

Leukaemia UK recently announced that it will channel £600,000 into four new AML research projects. Technology Networks spoke to Kate Nash, research communications manager at Leukaemia UK, to learn more about the innovative research projects aiming to improve the treatment of AML.
Silhouette of a human surrounded by health symbols.
Article

The Future of Digital Health With Professor Michael Snyder

Professor Michael Snyder performed the first longitudinal detailed integrative personal omics profile and used this to assess disease risk and monitor disease states. Technology Networks invited Snyder to an Ask Me Anything session to answer your questions about the future of digital health.

Sweetener on a metal spoon.
News

Could Artificial Sweeteners Have a Future in Autoimmunity Treatment?

A study raises the possibility that a common sweetener could suppress T-cell activation in humans, leading to potential therapeutic applications for managing diseases where excessive T-cell activation is problematic.
Illustration of a heart being bioprinted
Industry Insight

Human Tissue-Based Materials for 3D Bioprinting

Technology Networks spoke to Dr. Jasper Van Hoorick to learn more about the future of bioprinting, the benefits of animal-free bioinks and the development of human tissue-based bioinks.
Advertisement